Is Ibrance a form of chemo?
Key Points
- Ibrance (generic name: palbociclib) is not a traditional form of chemotherapy (chemo). Ibrance is a "targeted drug therapy" known as a CDK 4/6 inhibitor. Targeted therapies work only on certain cancers with specific genetic traits. For example, some cancer cells have proteins, like CDK, HER2 or mTOR, that promote rapid or unusual growth.
- Your doctor can test you to see if you have the kind of cancer that would respond to targeted drug therapy.
- Because these drugs target specific areas, they may be linked with fewer, less severe or different side effects compared to traditional chemotherapy. However, serious risks are still present, so be sure to discuss your options for cancer treatment with your physician.
What is chemo?
Chemotherapy ("chemo") is when oral or injectable medicines are used to kill cancer cells. Chemotherapy can also affect healthy cells, but the body can often repair the damage done to the healthy cell once treatment stops.
Chemotherapy can help prevent a cancer from coming back, from spreading in the body (metastasizing), and can kill cancer cells that have already spread.
Chemotherapy is usually given in cycles, with rest periods, over several months. Treatment is individualized for each patient and depends on several factors, such as cancer stage at diagnosis, previous treatments and how well you have tolerated other treatments.
Common chemotherapy treatments used in breast cancer include:
- the anthracyclines, such as doxorubicin (Adriamycin)
- epirubicin (Ellence)
- taxanes such as paclitaxel (Taxol) and docetaxel (Taxotere).
These may be combined with fluorouracil (5-FU), cyclophosphamide, and carboplatin.
Chemotherapy, endocrine (hormone) therapy, and targeted therapy are known as "adjuvant" systemic therapies. Adjuvant therapy for breast cancer is given after primary treatment (such as surgery) to increase the chance of long-term survival and may also include radiation.
How does Ibrance work in breast cancer?
Targeted drugs like Ibrance can be used with certain hormone therapies to fight advanced hormone receptor-positive (HR+) breast cancer in patients who are also determined to be HER2-negative.
Ibrance blocks CDK4 and CDK6, which are special proteins in the cell. Blocking these proteins helps to slow down cell division that leads to new cancer cell growth.
Related questions
- Will insurance pay for the cost of Ibrance?
- Is Verzenio better than Ibrance?
- Can you take Verzenio after Ibrance fails?
How is Ibrance used to treat breast cancer?
Ibrance is used two ways:
- with the aromatase inhibitor Femara (letrozole) as initial endocrine-based therapy in postmenopausal women and men
- with the estrogen receptor antagonist Faslodex (fulvestrant) in those with disease progression following endocrine therapy. Women who have not reached menopause are treated with Ibrance plus fulvestrant therapy and a luteinizing hormone-releasing hormone (LHRH) agonist to suppress ovarian function, according to current clinical practice standards.
Ibrance comes as capsule or a tablet, although the capsule form is being phased out in 2020. Ibrance capsules must be taken with food, but the tablets can be taken with or without food.
- Ibrance is normally given for 21 days in a row along with other medications, such as an aromatase inhibitor or fulvestrant.
- This cycle is repeated every 28 days as long as you are having a positive response to the medicine and tolerate the side effects well.
- Side effects due to Ibrance may include increased infections, low red blood cell counts (anemia), tiredness, nausea, hair loss, diarrhea and mouth sores.
- Tablets and capsules are both available in a 125 mg, 100 mg, and 75 mg strength.
Bottom Line
- Ibrance is not a traditional form of chemotherapy. It is an oral medication known as a “targeted therapy” and is in the class of drugs known as CDK 4/6 inhibitors. It helps to slow cell growth in both cancer cells and healthy cells.
- Ibrance comes as a capsule or tablet, although the capsules are being phased out by the manufacturer in 2020. It is normally given for 21 days in a row along with other medications, such as an aromatase inhibitor or fulvestrant.
- This cycle is repeated every 28 days as long as you are responding to the medicine and you don’t have serious side effects.
This is not all the information you need to know about Ibrance (generic name: palbociclib) for safe and effective use. Review the full Ibrance product information here, and discuss this information with your doctor or other health care provider.
References
- Ibrance [package insert]. New York, NY: Pfizer, Nov. 2019.
- Pfizer.com. Ibrance tablets. Accessed May 5, 2020 at https://www.ibrance.com/tablets
- Breastcancer.org. Ibrance. Accessed May 5, 2020 at https://www.breastcancer.org/treatment/targeted_therapies/ibrance
- Breast Cancer Therapy: Right On Target. drugclasses.com. Accessed June 25, 2020 at https://www.drugclasses.com/slideshow/breast-cancer-therapy-right-on-target-1208
Read next
What are 10 key Ibrance side effects to watch out for?
Common side effects of Ibrance include low blood cell counts, nausea, vomiting, diarrhea, rash, hair loss, and fatigue. Most side effects go away after pausing or stopping treatment. More serious side effects of Ibrance that are less common or rare include interstitial lung disease and pneumonitis. Continue reading
What is the strongest chemotherapy drug for breast cancer?
Doxorubicin is considered one of the strongest chemotherapy drugs for breast cancer ever invented. It can kill cancer cells at every point in their life cycle, and it's used to treat a wide variety of cancers, not just breast cancer. Doxorubicin is also known as “The Red Devil” because it is a clear bright red color. It can cause your urine or other body fluids to turn a reddish color for 1 to 2 days after a dose is given, which is normal and temporary. Continue reading
How long do letrozole side effects last?
Most side effects of letrozole are mild and temporary, lasting only a few days or weeks until your body gets used to taking the medication. Some other side effects of letrozole take a few months to develop and tend to persist long term until you stop taking letrozole. The half-life of letrozole is 2 days, so once you stop taking letrozole, you might continue to experience side effects for about a week to 10 days after your last dose. Continue reading
Related medical questions
- How long can you take Ibrance?
- How common is hair loss with Ibrance?
- How does Ibrance kill cancer?
- How effective is Ibrance?
- Why are my nipples sore? 7 possible causes
- What happens when you stop taking letrozole?
- Does anastrozole cause hair loss?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- What is the success rate of Keytruda?
- What does anastrozole do to your body?
- What are monoclonal antibodies?
- Is letrozole a form of chemotherapy?
- What is the lifetime or cumulative dose for Adriamycin?
- Does Femara make your hair fall out?
- Why give Taxol (Paxel) before carboplatin?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- Does letrozole affect blood sugar levels?
- How does AC (Adriamycin and Cytoxan [cyclophosphamide]) work for Breast Cancer?
- What is the success rate for Femara in breast cancer?
- Why do you need to take Xeloda with food?
- What are the long-term side effects of Adriamycin?
- Is it common to lose hair AFTER stopping tamoxifen?
- Which is better - Aromasin or Femara?
- How long can you stay on Herceptin and Perjeta?
- How long do you take Verzenio for?
- How long does Herceptin stay in your body?
- What is Paxel called in the USA?
- How long can you take Faslodex?
- What happens after Herceptin treatment?
- How effective is Trodelvy?
Drug information
Related support groups
- Ibrance (10 questions, 28 members)
- Palbociclib (7 questions, 10 members)
- Breast Cancer (122 questions, 304 members)
- Breast Cancer, Metastatic (56 questions, 80 members)
- Breast Cancer - Male (9 questions, 5 members)